Coprocytobiology: On the nature of cellular elements from stools in the pathophysiology of colonic disease

Journal of Clinical Gastroenterology

Volumn 36, Issue 5 SUPPL., 2003, Pages

  Nair, Padmanabhan ^a,c   Lagerholm, Sara ^a,b   Dutta, Sudhir ^b   Shami, Samina ^a   Davis, Kirk ^a   Ma, Shuzhen ^a   Malayeri, Mehran ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b SINAI HOSPITAL OF BALTIMORE   (United States)

^c NonInvasive Technologies   (United States)

Author keywords

Colonic disease; Coprocytobiology; Pathophysiology

Indexed keywords

ANTIGEN; BETA ACTIN; CARCINOEMBRYONIC ANTIGEN; CD45 ANTIGEN; COMPLEMENTARY DNA; CYCLOOXYGENASE 2; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 8; DNA; HERMES ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INSULIN RECEPTOR; JACALIN; MESSENGER RNA; PLANT LECTIN; PROTEIN KINASE C; PROTEIN P53; WHEAT GERM AGGLUTININ;

ANTIGEN EXPRESSION; BIOTECHNOLOGY; CANCER SCREENING; CELL ISOLATION; CELL TRANSFORMATION; COLON DISEASE; COLON TUMOR; COLORECTAL CANCER; CONFERENCE PAPER; COPROCYTOBIOLOGY; CYTODIAGNOSIS; CYTOLOGY; DISEASE MARKER; DNA SYNTHESIS; DOWNSTREAM PROCESSING; ENTERITIS; FECES ANALYSIS; GASTROINTESTINAL TRACT; GENE EXPRESSION; GENE MUTATION; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HUMAN; MOLECULAR CLONING; MORPHOLOGY; MUCOSAL IMMUNITY; MULTIDRUG RESISTANCE; PATHOPHYSIOLOGY; PEANUT; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA ISOLATION; SOMATIC CELL; STOMACH EPITHELIUM; WHEAT GERM;

ANTIGENS, NEOPLASM; COLON; COLONIC NEOPLASMS; FECES; GENE EXPRESSION; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 0037404409     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200305001-00015     Document Type: Conference Paper

References (80)

1. Albaugh GP, lyengar V, Lohani A, et al. Recovery and characterization of exfoliated intestinal tract cells from fresh human stools by countercurrent centrifugal elutriation. J Cell Biol 1989;107:575A.
2. Iyengar V, Albaugh GP, Lohani A, et al. Cytologic and immunochemical characterization of colonic cells isolated from human stools by density gradient. FASEB J 1990;4:A1165.
3. Iyengar V, Albaugh GP. Lohani A. et al, Human stools as a source of viable colonic epithelial cells. FASEB J 1991;5:2856-9.
4. Albaugh GP, Iyengar V, Lohani A, et al. Isolation of exfoliated colonic epithelial cells: a novel non-invasive approach to the study of cellular markers. Int J Cancer 1992:52:347-50.
5. Davidson LA, Jiang YH, Derr JN. et al, Protein kinase C isoforms in human and rat colonic mucosa. Arch Biochem Biophys 1994;312:547-53.
6. Dutta SK, Silverstein RJ, Fleischer AS. et al. Increased expression of CD44 in isolated fecal colonocytes in patients with colonic neoplasia. Gastroenterology 1995;108:A396.
7. Yamao J, Matsumura Y, Shimada Y, et al. Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal adenocarcinoma. Gastroenterology 1998;114:1196-205.
8. Loktionov A, O'Neill IK, Silvester KR. et al. Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel non-invasive screening test for colorectal cancer. Clin Cancer Res 1998:4:337-42.
9. Dutta SK, Nair PP. Noninvasive detection of colorectal cancer by molecular tools: coming of age [editorial]. Gastroenterology 1998;114:1333-5.
10. Cremins J, Salata K, Kikendall W. et al. PNA binding to isolated colonocyte may diagnose colon carcinoma. Gastroenterology 1994; 106:A379.
11. Agency for Health Care Policy and Research (AHCPR), Research Activity 1997;200:15-8.
12. American Cancer Society, Cancer Facts and Figures - 2000. Atlanta, GA: American Cancer Society, 2000.
13. Dukes CE. Classification of cancer of the rectum. J Pathol Bacteriol 1932;35:325-32.
14. Devesa SS, Silverman DT, Young JL, et al. Cancer incidence and mortality trend among whites in USA (1947-84). JNCI 1987;79:701-70.
15. Calkins B, Mendeloff AI. The epidemiology of idiopathic inflammatory bowel disease, In: Kirsner JB, Shorter RG. eds. Inflammatory Bowel Disease. 4th ed. Baltimore: Williams & Wilkins. 1995:31-68,
16. Kadish SL, Brandt LJ. Inflammatory bowel disease in the elderly. In: Kirsner JB, Shorter RG. eds. Inflammatory Bowel Disease, 4th ed. Baltimore: Williams & Wilkins, 1995:390-406.
17. Gyde S. Screening for colorectal cancer in ulcerative colitis: dubious benefits and high costs. Gut 1990;31:1089-92.
18. Gyde SN. Cancer in inflammatory bowel disease. Scand J Gastroenterol 1989; 24(suppl 170):79-80.
19. Gyde SN, Prior P, Allan RN, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centers. Gut 1988;29:206-17.
20. Ahlquist DA. Occult gastrointestinal bleeding. In: Yamada T. ed. Textbook for Gastroenterology. New York: JB Lippincott and Co, 1995:6699-721.
21. Wagner JL, Herdman RC. Wadhwa S. Cost-effectiveness of colorectal cancer screening in the elderly. Ann Intern Med 1991;115:807-17.
22. Ransohoff DF, Lang CA. Screening of colorectal cancer. N Engl J Med 1991;325:37-41.
23. Mandel JS. Bond JH. Bradley N, et al. Sensitivity, specificity and positive predictivity of Hemoccult test in screening for colorectal cancer, The University of Minnesota's Colon Cancer Control Study. Gastroenterology 1989;97:597-600.
24. Eddy DM. Screening of colorectal cancer. Ann Intern Med 1990;113:373-84.
25. Macrae FA. St. John JB, Caligiore P. et al. Optimal dietary conditions for Hemoccult testing. Gastroenterology 1982;82:899-903.
26. Eastwood GL. Gastrointestinal epithelial renewal. Gastroenterology 1977;72:962-75.
27. Messier B, Leblond CP. Cell proliferation and migration as revealed by radioautography after injection of thymidine 3H into rats and mice. Am J Anat 1960;106:247-94.
28. Chang WW, Leblond CP. Renewal of the epithelium in the descending colon of the mouse, I. Presence of three cell populations, vacuolated-columnar, mucus and argentaffin. Am J Anat 1971:131:73-100.
29. Lipkin M. Bell B, Sherlock P. Cell proliferation kinetics in the gastrointestinal tract of man. I. Cell renewal in colon and rectum. J Clin Invest 1963;42:767-76.
30. Lipkin M. Proliferation and differentiation of gastrointestinal cells. Physiol Rev 1973;53:891-915.
31. Mehls LE. A mathematical computer simulation model for the development of colonic polyps and colon cancer. J Surg Oncol 1991;4:242-52.
32. Shorter RG. Moertel CG, Titus JL, et al. Cell kinetics in the jejunum and rectum of man. Am J Dig Dis 1964;9:760-3.
33. Tribukait B. Hammerberg C, Rubio C. Ploidy and proliferation patterns in colorectal adenocarcinomas related to Duke's classification and to histopathologic differentiation: a flow cytometric DNA study. Acta Pathol Microbiol Scand 1983: 91:89-95.
34. Quirke P, Dixon MF, Clayden AD, et al. Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinoma. J Pathol 1987;151:285-91.
35. Nigro JM, Barker SJ. Preisinger AC, et al. Mutations in the p53 gene occur in diverse human tumor types. Nature 1989;342:705-8.
36. Rosenbach O. Uber die anwesenheit yon Geschwulst partikeln in dem durch die magenpumpe entleerten mageninhalte bei karzinoma ventriculi. Dtsch Med Wochenschr 1882;33:452.
37. Reineboth K. Die diagnose des magenkarzinoms aus spulwasser und enbrochenem. Dtsch Arch Klin Med 1896;58:63.
38. Bader GM, Papanicolaou GN. The application of cytology in the diagnosis of cancer of the rectum, sigmoid and descending colon. Cancer 1952;2:307-14.
39. Ruskin HF, Palmer WL. Kirsner JB. Exfoliative cytology in the diagnosis of cancer of the colon, Dis Colon Rectum 1959;2:46-57.
40. Cameron AB, Thabet RJ. Recovery of malignant cells from enema returns in carcinoma of the colon. Surg Forum 1959;10:30-3.
41. Rosenberg IL, Giles GR. The value of colonic exfoliative cytology in the diagnosis of carcinoma of the large intestine. Dis Colon Rectum 1977;20:1-10.
42. Fujimoto S. Kitsukawa Y, Itoh K. Clinical value of fecal CEA as an aid to diagnosis. Cell Mol Biol 1979;25:153-61.
43. Stubbs RS, Nadkarni DM, Monsey HA. Fecal carcinoembryonic antigen (CEA) in patients with large bowel cancer. Eur J Surg Oncol 1987;13:433-6.
44. Shimano T. Okuda H, Mouden T, et al. Usefulness of carcinoembryonic antigen measurements in feces of patients with colorectal cancer. Dis Colon Rectum 1987;30:607-10.
45. Rosman AS, Feinman L, Federman Q, et al. Diagnosis of colon cancer by lavage using an orally administered balanced electrolyte solution (Colyte). Gastroenterology 1988;94:A386.
46. Shamsuddin AM, Elsayed AM. A test for the detection of colorectal cancer. Hum Pathol 1988;19:7-12.
47. Sugano K, Ohkura H, Hirohashi S. et al. Detection of increased fecal carcinoembryonic antigen and its characterization as a membrane-bound form in colorectal carcinoma and other gastrointestinal disorders. Jpn J Cancer Res 1989;80:1156-60.
48. Egan J, Salata K, Cremins J, et al. CD45 positive cells in feces: a marker for disease activity in IBD. Gastroenterology 1995;108:A814.
49. Pant KD, Zamora PO. Saas KS. et al. A comparison of monoclonal antibodies against distinct colon-tumor-associated antigens in immunohistochemistry and in tumor localization. Nucl Med Biol 1987;14:81-9.
50. Szulman AE. The histologic distribution of blood-group substances A & B in man. J Exp Med 1962;111:785-800.
51. Wiley EL, Murphy P. Mendelsohn G, et al. Distribution of blood-group substances in normal human colon. Use of the unlabeled antibody (PAP) immunoperoxidase technique to identify A & B blood-group substances. Am J Clin Pathol 1981:76:806-9.
52. Gold P, Friedman S. Demonstration of tumor-specific antigens in human colon carcinomata by immunologic tolerance and absorption techniques. J Exp Med 1965:121:439-62.
53. Benchimol S, Fuks A, Jothy S, et al. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 1989;57:327-34,
54. Ebina Y, Ellis L, Jarnagin K, et al. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signaling. Cell 1985;40:747-58.
55. Mountjoy KG, Holdaway IM, Findlay GJ. Insulin receptor regulation in cultured human tumor cells. Cancer Res 1983;43:4537-42.
56. Forgue-Lafitte ME, Horvat A, Rosselin G. Insulin binding by a cell line (HT 29) derived from human colonic cancer. Mol Cell Endocrinol 1979;41:123-30.
57. Seino S, Bell GI. Alternative splicing of the human insulin receptor messenger RNA. Biochem Biophys Res Commun 1989;159:312-6.
58. Malayeri M, Albaugh G, Davis R, et al. Exfoliated human colonic epithelial cells: insulin binding and molecular cloning of the insulin receptor. Med Sci Res 1997;25:801-3.
59. Boland CR, Montgomery CK, Kim YS, Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation. Proc Natl Acad Sci USA 1982;79:2051-5.
60. Cooper HS. Peanut lectin binding sites in large bowel carcinoma. Lab Invest 1982;47:383-90.
61. Elsayed AM, Jockle G, Shamsudding AKM. Peanut agglutinin as a marker for preneoplastic and neoplastic changes in human and rat colon. Proc Am Assoc Cancer Res 1987;27:201.
62. Boland CR, Roberts JA, Siddiqui B, et al. Cancer-associated colonic mucins in cultured tumor cells and nude mouse xenografts. Cancer Res 1986;46:5724-9.
63. Itzkowitz SH, Young E, Dubois D, et al. Sialosyl-Tn antigen is prevalent and precedes dysplasia in ulcerative colitis: a retrospective case-control study. Gastroenterology 1996;110:694-704.
64. Desilets DJ, Davis KE, Nair PP. et al. Lectin binding to human colonocytes is predictive of colonic neoplasia. Am J Gastroenterol 1999;94:744-50.
65. Ma S. Wong RKH, Kikendall JW, et al. Detection of P53 gene mutations in exfoliated human colonic epithelial cells isolated from stools of subjects undergoing colonoscopy. Gastroenterology 1993;104(suppl):A454.
66. Jalkanen S, Reichert RA, Gallatin WM, et al. Homing receptors and the control of lymphocyte migration. Immunol Rev 1986;91:39-60.
67. Jalkanen S, Jalkanen M, Bargatze R. et al. Biochemical properties of glycoprotein involved in lymphocyte recognition of high endothelial venules in man. J Immunol 1988;141:1615-23.
68. Jackson DG, Buckley J, Bell JI. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 1992;267:4732-9.
69. Cooper DL, Dougherty G, Harn HJ, et al. The complex CD44 transcriptional unit: alternative splicing of three internal exons generates the epithelial form of CD44. Biochem Biophys Res Commun 1992;182:569-78.
70. Screaton GR, Bell MV, Bell JI, et al. Identification of a new alternative exon with highly restrictive tissue expression in transcripts encoding the mouse Pgp-1 (CD 44) homing receptor. Comparison of all ten variable exons between mouse, human and rat. J Biol Chem 1993:268:12235-8.
71. Matsumura Y, Tarin D. Significance of CD 44 gene products for cancer diagnosis and disease evaluation. Lancet 1992;340:1053-8.
72. Heider KH, Hoffman M, Hors E, et al. A human homologue of the rat metastasis-associated variant of CD 44 is expressed in colorectal carcinomas and adenomatous polyps, J Cell Biol 1993;120:223-7.
73. Guo YJ, Lin G, Wang X. et al. Potential use of soluble CD 44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res 1994:54:422-6.
74. Wielenga VJM, Heider KH, Offenhaus GJA, et al. Expression of CD 44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993;54:4754-6.
75. Tanabe KN, Ellis LM, Saya H. Expression of CD 44R! adhesion molecules in colon carcinomas and metastasis. Lancet 1993:341:725-6.
76. Dutta SK, Ashktorab H, Vinayek SM, et al. Evaluation of CD44 expression in isolated fecal colonocytes as a marker for noninvasive detection of colonic polyp and cancer. Gastroenterology 1996;110:A510.
77. Lagerholm S, Dutta SK, Merchant NB, et al. COX-2 expression in fecal colonocytes from patients with inflammatory bowel disease (IBD) [abstract 16]. DDW May 2001.
78. Mostov KE, Blobel G. A transmembrane precursor of secretory component. J Biol Chem 1982;257:11816-21.
79. Brandtzaeg P. Halstensen TS, Kett K, et al. Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes, Gastroenterology 1989;97:1562-84.
80. Mitscher LA, Pillai SP, Gentry EJ, et al. Multiple drug resistance. Med Res Rev 1999;19:477-96.